Mads Hald Andersen

Mads Hald Andersen

Clinical Professor

Member of:


    1. 2020
    2. Published

      Staphylococcus aureus alpha-toxin inhibits CD8+ T cell-mediated killing of cancer cells in cutaneous T-cell lymphoma

      Blümel, E., Munir Ahmad, S., Nastasi, C., Willerslev-Olsen, A., Gluud, M., Fredholm, S., Hu, T., Surewaard, B. G. J., Lindahl, L. M., Fogh, H., Koralov, S. B., Rahbek Gjerdrum, L. M., Clark, R. A., Iversen, L., Krejsgaard, T., Bonefeld, C. M., Geisler, C., Becker, J. C., Woetmann, A., Andersen, M. H. & 2 others, Buus, Terkild Brink & Ødum, Niels, 2020, In: OncoImmunology. 9, 1, 9 p., 1751561.

      Research output: Contribution to journalJournal articleResearchpeer-review

    3. Published

      Staphylococcus aureus enterotoxins induce FOXP3 in neoplastic T cells in Sézary syndrome

      Willerslev-Olsen, A., Buus, Terkild Brink, Nastasi, C., Blümel, E., Gluud, Maria, Bonefeld, Charlotte Menne, Geisler, Carsten, Lindahl, L. M., Vermeer, M., Wasik, M. A., Iversen, L., Becker, J. C., Andersen, Mads Hald, Gjerdrum, Lise Mette Rahbek, Litvinov, I. V., Litman, Thomas, Krejsgaard, T., Woetmann, Anders & Ødum, Niels, 2020, In: Blood Cancer Journal. 10, 5, 11 p., 57.

      Research output: Contribution to journalJournal articleResearchpeer-review

    4. Published

      Cancer immune therapy for Philadelphia chromosome-negative chronic myeloproliferative neoplasms

      Holmström, M. O., Hasselbalch, Hans Carl & Andersen, Mads Hald, 2020, In: Cancers. 12, 7, p. 1-21 21 p., 1763.

      Research output: Contribution to journalReviewResearchpeer-review

    5. Published

      Evidence of immune elimination, immuno-editing and immune escape in patients with hematological cancer

      Holmström, M. O., Cordua, S., Skov, V., Kjær, L., Pallisgaard, N., Ellervik, Christina, Hasselbalch, Hans Carl & Andersen, Mads Hald, 2020, In: Cancer Immunology, Immunotherapy. 69, p. 315–324

      Research output: Contribution to journalReviewResearchpeer-review

    6. Published

      Healthy donors harbor memory T cell responses to RAS neo-antigens

      Holmström, M. O. & Andersen, Mads Hald, 2020, In: Cancers. 12, 10, p. 1-16 16 p., 3045.

      Research output: Contribution to journalJournal articleResearchpeer-review

    7. Published

      Leveraging Endogenous Dendritic Cells to Enhance the Therapeutic Efficacy of Adoptive T-Cell Therapy and Checkpoint Blockade

      Hübbe, M. L., Jæhger, D. E., Andresen, T. L. & Andersen, Mads Hald, 2020, In: Frontiers in Immunology. 11, 578349.

      Research output: Contribution to journalReviewResearchpeer-review

    8. Published

      MicroRNAs in the pathogenesis, diagnosis, prognosis and targeted treatment of cutaneous T-cell lymphomas

      Gluud, Maria, Willerslev-Olsen, A., Gjerdrum, Lise Mette Rahbek, Lindahl, L. M., Buus, Terkild Brink, Andersen, Mads Hald, Bonefeld, Charlotte Menne, Krejsgaard, T., Litvinov, I. V., Iversen, L., Becker, J. C., Persson, J. L., Koralov, S. B., Litman, Thomas, Geisler, Carsten, Woetmann, Anders & Ødum, Niels, 2020, In: Cancers. 12, 5, 18 p., 1229.

      Research output: Contribution to journalReviewResearchpeer-review

    9. Published

      Peptide Vaccination Against PD-L1 With IO103 a Novel Immune Modulatory Vaccine in Multiple Myeloma: A Phase I First-in-Human Trial

      Jørgensen, N. G., Klausen, U., Grauslund, J. H., Helleberg, C., Aagaard, T. G., Do, T. H., Ahmad, S. M., Olsen, L. R., Klausen, T. W., Breinholt, M. F., Hansen, M., Martinenaite, E., Met, Özcan, Svane, Inge Marie, Knudsen, L. M. & Andersen, Mads Hald, 2020, In: Frontiers in Immunology. 11, 11 p., 595035.

      Research output: Contribution to journalJournal articleResearchpeer-review

    10. Published

      Peptide vaccination directed against IDO1-expressing immune cells elicits CD8 + and CD4 + T-cell-mediated antitumor immunity and enhanced anti-PD1 responses

      Dey, S., Sutanto-Ward, E., Kopp, K. L., Duhadaway, J., Mondal, A., Ghaban, D., Lecoq, I., Zocca, M. B., Merlo, L. M. F., Mandik-Nayak, L., Andersen, Mads Hald, Pedersen, A. W. & Muller, A. J., 2020, In: Journal for ImmunoTherapy of Cancer. 8, 2, 2020000605.

      Research output: Contribution to journalJournal articleResearchpeer-review

    11. Published

      The metabolic enzyme arginase-2 is a potential target for novel immune modulatory vaccines

      Weis-Banke, S. E., Hübbe, M. L., Holmström, M. O., Jørgensen, M. A., Bendtsen, S. K., Martinenaite, E., Carretta, M., Svane, Inge Marie, Ødum, Niels, Pedersen, A. W., Met, Özcan, Madsen, D. H. & Andersen, Mads Hald, 2020, In: OncoImmunology. 9, 1, 16 p., 1771142.

      Research output: Contribution to journalJournal articleResearchpeer-review

    ID: 13571778